NO20032328L - protease inhibitors - Google Patents

protease inhibitors

Info

Publication number
NO20032328L
NO20032328L NO20032328A NO20032328A NO20032328L NO 20032328 L NO20032328 L NO 20032328L NO 20032328 A NO20032328 A NO 20032328A NO 20032328 A NO20032328 A NO 20032328A NO 20032328 L NO20032328 L NO 20032328L
Authority
NO
Norway
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Application number
NO20032328A
Other languages
Norwegian (no)
Other versions
NO20032328D0 (en
Inventor
Daniel F Veber
Robert W Marquis
Dennis Shinji Yamashita
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20032328D0 publication Critical patent/NO20032328D0/en
Publication of NO20032328L publication Critical patent/NO20032328L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20032328A 2000-11-22 2003-05-22 protease inhibitors NO20032328L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25250800P 2000-11-22 2000-11-22
PCT/US2001/051647 WO2003053331A2 (en) 2000-11-22 2001-11-19 Protease inhibitors

Publications (2)

Publication Number Publication Date
NO20032328D0 NO20032328D0 (en) 2003-05-22
NO20032328L true NO20032328L (en) 2003-07-02

Family

ID=22956303

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032328A NO20032328L (en) 2000-11-22 2003-05-22 protease inhibitors

Country Status (17)

Country Link
EP (1) EP1392657A4 (en)
JP (1) JP2005513083A (en)
KR (1) KR20040004445A (en)
CN (1) CN1635903A (en)
AR (1) AR034278A1 (en)
AU (1) AU2001298052A1 (en)
BR (1) BR0115473A (en)
CA (1) CA2436850A1 (en)
CZ (1) CZ20031403A3 (en)
HU (1) HUP0301964A3 (en)
IL (1) IL155997A0 (en)
MX (1) MXPA03004542A (en)
NO (1) NO20032328L (en)
PL (1) PL366232A1 (en)
UY (1) UY27032A1 (en)
WO (1) WO2003053331A2 (en)
ZA (1) ZA200303848B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
HUP0300068A2 (en) 2000-03-21 2003-05-28 Smithkline Beecham Corp Protease inhibitors, their preparation, their use and pharmaceutical compositions containing them
MXPA02012442A (en) * 2000-06-14 2003-04-25 Smithkline Beecham Corp Protease inhibitors.
EP2168600A1 (en) 2007-06-08 2010-03-31 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for cerebral aneurysm
JPWO2009054454A1 (en) 2007-10-24 2011-03-03 国立大学法人 東京医科歯科大学 Modulator of signal transduction of Toll-like receptor containing cathepsin inhibitor as an active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9916488A (en) * 1998-12-23 2001-10-09 Smithkline Beecham Corp Protease inhibitors
HUP0300068A2 (en) * 2000-03-21 2003-05-28 Smithkline Beecham Corp Protease inhibitors, their preparation, their use and pharmaceutical compositions containing them
MXPA02012442A (en) * 2000-06-14 2003-04-25 Smithkline Beecham Corp Protease inhibitors.

Also Published As

Publication number Publication date
PL366232A1 (en) 2005-01-24
NO20032328D0 (en) 2003-05-22
HUP0301964A3 (en) 2007-09-28
AR034278A1 (en) 2004-02-18
EP1392657A4 (en) 2004-03-10
BR0115473A (en) 2004-09-28
WO2003053331A3 (en) 2003-11-13
AU2001298052A1 (en) 2003-07-09
UY27032A1 (en) 2002-07-31
KR20040004445A (en) 2004-01-13
EP1392657A2 (en) 2004-03-03
JP2005513083A (en) 2005-05-12
WO2003053331A2 (en) 2003-07-03
CZ20031403A3 (en) 2003-10-15
CN1635903A (en) 2005-07-06
CA2436850A1 (en) 2003-07-03
HUP0301964A2 (en) 2007-02-28
IL155997A0 (en) 2003-12-23
ZA200303848B (en) 2004-06-28
MXPA03004542A (en) 2003-09-10

Similar Documents

Publication Publication Date Title
CY2012007I2 (en) PEPTIDEMIMETIC PROTEASE INHIBITORS
NO20012980L (en) protease inhibitors
ATE484496T1 (en) METALLOPROTEINASE INHIBITORS
EE200300439A (en) Metalloproteinase inhibitors
DE60002193D1 (en) METALOPROTEASE INHIBITORS
IL150964A0 (en) Protease inhibitors
ATE325091T1 (en) ASPARTYL PROTEASE INHIBITORS
EE200300450A (en) Metalloproteinase inhibitors
DK1272488T3 (en) Tri-aryl-substituted ethane-PDE4 inhibitors
NO20014243D0 (en) Dihetero-substituted metalloprotease inhibitors
NO20025786L (en) protease inhibitors
NO20025005D0 (en) protease inhibitors
NO20032328D0 (en) protease inhibitors